Morgan Stanley Astria Therapeutics, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 229,711 shares of ATXS stock, worth $2.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

229,711

Previous 110,660 107.58%

Holding current value

$2.22 Million

Previous $1.01 Million 151.14%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$8.97 - $12.65 $1.07 Million - $1.51 Million	119,051 Added 107.58%	229,711 $2.53 Million
Q2 2024 Oct 17, 2024	SELL	$8.83 - $13.51 $1.01 Million - $1.55 Million	-114,895 Reduced 50.94%	110,660 $1.01 Million
Q2 2024 Aug 14, 2024	SELL	$8.83 - $13.51 $1.01 Million - $1.55 Million	-114,895 Reduced 50.94%	110,660 $1.01 Million
Q1 2024 Oct 17, 2024	BUY	$6.99 - $16.69 $803,116 - $1.92 Million	114,895 Added 103.83%	225,555 $3.17 Million
Q1 2024 Aug 16, 2024	SELL	$6.99 - $16.69 $1.06 Million - $2.54 Million	-151,983 Reduced 40.26%	225,555 $3.17 Million
Q1 2024 May 15, 2024	SELL	$6.99 - $16.69 $1.06 Million - $2.54 Million	-151,983 Reduced 40.26%	225,555 $3.17 Million
Q4 2023 Aug 16, 2024	BUY	$4.42 - $8.06 $1.18 Million - $2.15 Million	266,878 Added 241.17%	377,538 $2.9 Million
Q4 2023 Feb 13, 2024	BUY	$4.42 - $8.06 $1.52 Million - $2.77 Million	344,188 Added 1032.05%	377,538 $2.9 Million
Q3 2023 Nov 15, 2023	SELL	$6.89 - $9.86 $141,885 - $203,046	-20,593 Reduced 38.18%	33,350 $248,000
Q2 2023 Aug 14, 2023	SELL	$8.33 - $13.72 $249,116 - $410,310	-29,906 Reduced 35.67%	53,943 $449,000
Q1 2023 May 15, 2023	BUY	$11.2 - $15.79 $717,068 - $1.01 Million	64,024 Added 322.95%	83,849 $1.12 Million
Q4 2022 Feb 14, 2023	BUY	$7.44 - $14.89 $67,852 - $135,796	9,120 Added 85.19%	19,825 $295,000
Q3 2022 Nov 14, 2022	BUY	$2.97 - $10.34 $24,365 - $84,829	8,204 Added 328.03%	10,705 $97,000
Q2 2022 Oct 27, 2022	SELL	$2.46 - $6.96 $1,247 - $3,528	-507 Reduced 16.86%	2,501 $8,000
Q2 2022 Aug 15, 2022	SELL	$2.46 - $6.96 $1,247 - $3,528	-507 Reduced 16.86%	2,501 $8,000
Q1 2022 Oct 27, 2022	BUY	$3.92 - $7.1 $1,987 - $3,599	507 Added 20.27%	3,008 $20,000
Q1 2022 May 13, 2022	SELL	$3.92 - $7.1 $219 - $397	-56 Reduced 1.83%	3,008 $20,000
Q4 2021 Feb 14, 2022	SELL	$5.08 - $8.62 $25 - $43	-5 Reduced 0.16%	3,064 $16,000
Q3 2021 Nov 15, 2021	BUY	$7.32 - $12.9 $22,465 - $39,590	3,069 New	3,069 $28,000

Others Institutions Holding ATXS

# of Institutions

107

Shares Held

48.6M

Call Options Held

48K

Put Options Held

9.3K

View Full List

About Astria Therapeutics, Inc.

Ticker ATXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,178,000
Market Cap $146M
Description
Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...

More about ATXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account